Vol 7: Randomized controlled clinical trial of a combination therapy of vildagliptin plus an -glucosidase inhibitor for patients with type II diabetes mellitus.Report as inadecuate



 Vol 7: Randomized controlled clinical trial of a combination therapy of vildagliptin plus an -glucosidase inhibitor for patients with type II diabetes mellitus.


Vol 7: Randomized controlled clinical trial of a combination therapy of vildagliptin plus an -glucosidase inhibitor for patients with type II diabetes mellitus. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 7: Randomized controlled clinical trial of a combination therapy of vildagliptin plus an -glucosidase inhibitor for patients with type II diabetes mellitus.
This article is from Experimental and Therapeutic Medicine, volume 7.AbstractThe aim of this study was to assess the efficacy of a combination therapy of vildagliptin plus an α-glucosidase inhibitor for patients with type II diabetes mellitus. Type II diabetic patients exhibiting poor glycemic control following α-glucosidase inhibitor treatment for at least two months were selected and randomly distributed into vildagliptin and placebo groups. The body weight, fasting blood glucose FBG, postprandial glucose PPG, glycated hemoglobin HBA1c and blood lipid levels and hepatorenal functions of the patients were determined before and 12 weeks after the trial. Following the trial, the FBG, PPG, HbA1c, cholesterol CHOL and triglyceride TG levels in the vildagliptin group were significantly decreased compared with the pretreatment levels P



Author: SU, YONG; SU, YA-LI; LV, LI-FANG; WANG, LI-MIN; LI, QUAN-ZHONG; ZHAO, ZHI-GANG

Source: https://archive.org/



DOWNLOAD PDF




Related documents